Robert J. Phelan

CFO Robert Phelan sells 5,314 shares at $135.40 avg ($719.5K) under pre-arranged 10b5-1 plan; retains 50,492 shares post-trade.

Robert J. Phelan, Chief Financial Officer, executed 2 separate sales totaling 5,314 shares for $719,499.20 under a 10b5-1 trading plan adopted on 2025-12-12, meaning this sale was scheduled rather than discretionary. His stake in Covista Inc. decreased from 55,806 shares to 50,492 shares, representing a -9.5% reduction. The sales occurred at a blended average price of $135.40, above the current price of $131.32, though the stock remains -3.4% below its 52-week high of $135.96 and has posted strong 30-day (+4.2%) and 90-day (+17.2%) gains. Given the pre-arranged nature of the transaction, price-timing considerations do not apply to this filing; the sale reflects scheduled execution under an established plan rather than a discretionary decision tied to current valuation or company condition.

CFO Phelan sells 10,000 CVSA shares; first open-market sale in 36 months after stock climbs steeply.

Phelan Robert J., Covista's Chief Financial Officer, executed his first open-market sale in the past three years, disposing of a meaningful position at a price near the stock's 52-week highs. The company itself remains financially healthy—profitable with solid revenue growth—and the CFO's prior Form 4 activity consisted entirely of stock-based compensation transactions, making this an actual *market* sale rather than a routine equity grant event. The timing is noteworthy: the stock has rallied sharply over the past month, and Phelan is selling into that strength rather than accumulating, which represents a shift from his historical pattern of only receiving and holding equity awards. While a single sale does not establish a trend, it does break a 36-month pattern of inaction in the open market and warrants attention as a potential signal about how the CFO is viewing valuation or liquidity at current levels.